Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Recovery article

MK-677 Benefits and Research Applications

Researchers are actively exploring MK-677 benefits, and there is strong research interest in the application of MK-677 to improve both body composition and athletic performance. But are there any MK-677 benefits backed up by scientific evidence? And what is th

By Recovery & Performance Peptides Editorial Team

Researchers are actively exploring MK-677 benefits, and there is strong research interest in the application of MK-677 to improve both body composition and athletic performance.

But are there any MK-677 benefits backed up by scientific evidence? And what is the scientific basis and research behind the effects of MK-677?

The study of growth hormone secretagogues and their effect on the body is still in its infancy and what we know is rapidly developing. It can be difficult to keep up with all the promising new compounds and the research that supports their use.

To assist researchers, this guide will outline the main MK-677 benefits that have been observed during past studies and explore how this research chemical has been dosed and administered.

Buy MK-677 from our top-rated vendor...

Disclaimer: Peptides.org contains information about products that are intended for laboratory and research use only, unless otherwise explicitly stated. This information, including any referenced scientific or clinical research, is made available for educational purposes only. Likewise, any published information relative to the dosing and administration of reference materials is made available strictly for reference and shall not be construed to encourage the self-administration or any human use of said reference materials. Peptides.org makes every effort to ensure that any information it shares complies with national and international standards for clinical trial information and is committed to the timely disclosure of the design and results of all interventional clinical studies for innovative treatments publicly available or that may be made available. However, research is not considered conclusive. Peptides.org makes no claims that any products referenced can cure, treat or prevent any conditions, including any conditions referenced on its website or in print materials.

What is MK-677?

MK-677 is a long-lasting non-peptide agonist of the Ghrelin receptor [1]. It has a chemical structure that allows it to mimic the activity of Ghrelin and thus stimulate the body to produce more growth hormone [2]. Ghrelin causes the body to release more GH [7, 8], ultimately leading to elevated levels of GH in the blood, and more GH available to cells [9].

Growth hormone (GH) plays an essential role in the body’s ability to regulate itself. GH is involved in a number of different processes, but it’s especially important for tissue repair functions: keeping skin healthy, recovering and repairing after injuries, and building muscle [3].

GH is secreted regularly from specialized cells in the pituitary gland called somatotrophs. It is secreted in multiple daily pulses and is governed by the circadian rhythm. It works by upregulating insulin-like growth factor-1 (IGF-1), which in turn helps stimulate the growth and repair of tissue.

But some people produce too little GH, due to either a condition at birth (GH deficiency) or as a result of advancing age. Old age is associated with a general decline in the body’s production and secretion of GH.

This, in turn, affects the body’s ability to repair tissue and build muscle. People who are deficient in GH tend to have lower muscle mass and strength [4], more fatty tissue [5], and body lipid concentrations that may contribute to vascular diseases [6].

One solution for low GH seems to be the class of chemicals called growth hormone secretagogues, and MK-677 is one of those. By mimicking Ghrelin and binding to the same receptors as Ghrelin, MK-677 has the same effect as Ghrelin does — it upregulates GH.

MK-677 is also known as Ibutamoren and L-163,191. Let’s take a deep dive into MK-677’s purported benefits.

MK-677 Benefits and Research Applications

MK-677 is a research chemical and there is currently no scientific evidence that it offers any benefits in healthy test subjects. However, there have been several studies that have observed its effects in elderly test subjects and cancer patients, and this is what they found; MK-677 has the ability to raise levels of growth hormone. Several studies have shown it is effective at increasing blood concentrations of GH. Here’s a summary of the main findings:

In one small study of GH deficient adult men, researchers found that both 10 mg and 50 mg of MK-677 daily led to significantly increased GH in the blood, as well as significantly more IGF-1. The study found that MK-677 was well-tolerated and did not lead to any serious adverse effects [10].

In another randomized double-blind study on elderly men and women, both 10 mg and 25 mg of daily oral administration of MK-677 resulted in significant increases in plasma GH levels. 25 mg even elevated the GH levels to levels common for young adults. MK-677 was well-tolerated with no serious side effects [11].

In a randomized control study of elderly adults, an intake of 0.05 mg of MK-677 per kilogram of body weight led to a 2-fold increase in blood GH levels. A higher dose of 0.1 mg/kg of body weight resulted in a 4-fold increase. No clinically significant side effects were observed [12].

In another study on obese individuals, an oral MK-677 dosage of 25 mg each day for 8 weeks led to a significant increase in blood GH [13].

Each of the above studies demonstrates that MK-677 has a pronounced effect on GH levels in human test subjects.

This begs the question: What are the benefits of increased GH?

The potential benefits of increased GH levels are numerous and well-established.

Strong Bones

Bones typically lose their density with age, and this can lead to conditions like osteoporosis. Some research suggests that increased GH levels in the blood can help improve bone density and support optimal bone health [14].

MK-677 has been directly linked to increased bone density. In one study, it was tested for its effect on markers of bone turnover and bone mineral density in postmenopausal women, who are especially prone to bone density losses. In that population, a daily dose of 25 mg of MK-677 was found to mitigate the reduction of bone density [15].

If further research confirms these early results, MK-677 could be an effective treatment for osteoporosis and other bone disorders associated with aging.

Muscle Growth

GH plays an essential role in the construction and maintenance of lean muscle tissue. Higher blood GH levels make it easier for the body to synthesize muscle after a workout. Several high-quality research studies have demonstrated that elevated GH levels in the blood result in increased muscle mass [16, 17].

That research is corroborated by studies of MK-677 that have found that an 8-week cycle of 25 mg MK-677 doses leads to an increase in lean body mass and muscle for some groups, including obese males [13]. It also has been found to be effective in reversing diet-induced protein catabolism, which occurs when the body breaks down muscle tissue to meet its protein needs [15].

These studies suggest MK-677 could be effective in building and maintaining muscle.

Diminished Fat Tissue

GH also plays a role in metabolism and lipolysis — the burning of fatty tissue. Research has found that when GH is elevated from secretagogue substances, in combination with an exercise program, body fat is burned more efficiently [16, 18].

Research on MK-677 in one group of obese individuals hasn’t demonstrated that it results in diminished fat tissue directly, but it has found that daily administration of MK-677 over an 8-week cycle led to a significant increase in energy expenditure and an increase in the basal metabolic rate [13]. The researchers concluded, “further studies are needed to evaluate whether a higher dose of MK-677 or a more prolonged treatment period can promote a reduction in body fat.”

Improved Sleep

We know that sleep and GH are part of the same complex process, although how they influence each other is unclear. For example, we know that GH levels are at their highest during sleep. And the relationship seems to go the other way, too: more GH seems to result in better sleep quality [19].

MK-677 in particular has been found to have a significant effect on sleep. In one study it was found that doses of 25 mg increase stage IV sleep by about 50% and increase REM sleep by 20% compared to a placebo [20].

Injury Recovery

Repair goes along with resting.

GH appears to play a central part in the process through which the body repairs tissue. So it makes sense that higher GH levels have been found to be associated with the faster recovery of tissue from injuries [21].

Anti-Aging Effects and Skin Repair

Research has shown that elevated GH levels appear to be beneficial for the skin [22].

GH is well-recognized for being able to improve skin quality in part by repairing and replacing the collagen that is responsible for making skin look smooth and elastic [23, 24].

MK-677 Side Effects

Research on MK-677 ibutamoren is still ongoing, so we’re continuing to learn about the substance.

So far, it appears that MK-677 is generally well-tolerated in test subjects; it has not been found to lead to serious adverse effects [10, 11]. However, the absence of evidence doesn’t mean that MK-677 is safe, rather there have been very few long-term studies involving this research chemical.

The available research and clinical trials have identified the following side effects that could be related to MK-677 [10, 11, 15]:

Increase in appetite

Headache

Diarrhea

Dry skin

Night sweats

Numbness and tingling

Abdominal pain

Transient flushing of the face

Side effects seem to be dose-dependent, meaning that higher doses are associated with a greater likelihood of experiencing side effects. The implication is that test subjects starting with lower doses may be less likely to experience side effects.

What about long-term side effects?

Well, long-term tests of the side effects of MK-677 are still scarce. In one study on elderly women, MK-677 was used safely and without serious adverse effects for 18-24 months [15]. Still, the long-term effects of the use of this substance are not yet clear.

MK-677 Dosage Guide

Studies differ in how they’ve administered the MK-677 dosage to study participants. The following doses have been used in the various studies conducted on MK-677 [10, 11, 13]:

10 mg, administered orally, once per day, for 2 weeks

50 mg, administered orally, once per day, for 2 weeks

10 mg administered orally, once per day, for 2 to 4 weeks

25 mg, administered orally, once per day, for 2 to 4 weeks

25 mg, administered orally, once per day, for 8 weeks

0.05 mg/kg of body weight, administered intravenously with saline, in a single instance

0.1 mg/kg of body weight, administered intravenously with saline, in a single instance

Based on that information and the commonalities between these MK-677 dosing regimes, it appears that a typical dosing schedule for research subjects could be as follows:

Between 10 and 50 mg. 25 mg seems to be the dose used most frequently for healthy adults.

Administered orally with water once per day, ideally on an empty stomach

For a cycle of 2 to 8 weeks, with several weeks off.

MK-677 Research Cycle

Again, the information we have on the ideal MK-677 cycle for test subjects isn’t clear because of the lack of high-quality research on the subject.

Based on most of the research we’ve seen, short-term studies typically use cycles that last for between 2 to 8 weeks, followed by several weeks off [10, 11, 13]. There is at least one study, however, that provided participants daily administration over 24 months and it was well-tolerated [25].

Where to Buy MK-677 Online? | 2024 Edition

Researchers who are looking to buy MK-677 for use in their work can find the compound for sale online.

Yet a concerning amount of online MK-677 vendors do not actually sell a legitimate, pure product. Accordingly, we encourage researchers to do due diligence on a vendor before placing an order, to ensure that they’re getting research-grade MK-677.

To help researchers along, here are our two favorite online vendors of MK-677, who we trust for their reliability and commitment to product quality.

Chemyo

In our experience, Chemyo is among the most trustworthy sources of research-grade compounds like MK-677. Here are their standout features:

High-Quality MK-677: Chemyo gets each batch of MK-677 independently tested and posts the corresponding laboratory reports on their website for all customers to view. This helps researchers ensure they’re getting a pure product.

Product Selection: This vendor currently offers MK-677 in both solution and powder form, and has one of the more extensive product selections in the industry.

Great Service: Chemyo runs its business with the researchers’s experience in mind. This commitment is evident from their care team, who are very helpful and prompt in resolving issues.

Limitless Life

Limitless Life is another trustworthy research chemicals vendor that stocks premium-grade MK-677.

Here’s why they are well-regarded by our team and the community at large:

Potent Peptides: Limitless Life ensures the potency and purity of their MK-677 by subjecting each batch to third-party HPLC-MS analysis.

Dependable Shipping: The vendor is very quick to dispatch orders, and waives shipping fees on orders over $350.

Buy research peptides from Triumphant Labs, a top-rated vendor...

Benefits of MK-677 | Verdict

MK-677 ibutamoren is a powerful addition to the group of GH secretagogues. The evidence consistently suggests that this substance does increase plasma GH levels. It also seems to have a wide range of other potential research benefits including:

Increased muscle

Decreased fat

Improved bone density

Better sleep

Researchers looking to study the effects of GH on the human body may find that MK-677 could be a worthwhile addition to their research program.

Looking to source MK-677? Just click here!

CONNECTED / MODULES

Post-session references

Selected from shared article topics. Source links are retained where available.

01

Handling & safety lane

Source-derived education, not individual medical guidance or an instruction to dose.

DOSAGE SOURCE

Why MK-677 Response Varies — Receptor Sensitivity and Dosing Thresholds

MK-677 binds to ghrelin receptors (GHS-R1a) in the hypothalamus and pituitary, triggering growth hormone secretion without suppressing the body's natural GH pulse rhythm. This is mechanistically different from exogenous GH administration. MK-677 amplifies existing pulsatile release rather than replacing it. The clinical threshold for measurable IGF-1 elevation is approximately 10mg daily, but optimal response in most subjects occurs at 20–25mg. Doses below 10mg produce inconsistent results because ghrelin receptor occupancy is insufficient to overcome negative feedback loops from elevated blood glucose or cortisol. The compound's half-life is approximately 24 hours, meaning daily dosing maintains stable plasma concentrations. Taking it sporadically. Three times per week, or 'when remembered'. Produces IGF-1 spikes that never accumulate into sustained anabolic signaling. Growth hormone's downstream effects (increased lipolysis, collagen synthesis, nitrogen retention) require weeks of elevated IGF-1 to manifest as measurable body composition changes. A user taking 15mg for 10 days then stopping for five days resets this accumulation cycle entirely. Insulin and glucose both suppress growth hormone release via somatostatin activation. MK-677 taken with a high-carbohydrate meal faces immediate hormonal antagonism. The ghrelin signal is present, but the insulin spike overrides it at the receptor level. Research published in the Journal of Clinical Endocrinology & Metabolism found …
SIDE EFFECTS

Managing and Mitigating Side Effects

You don't have to stop MK-677 at the first sign of discomfort. Many side effects can be managed: Eat high-fiber, protein-rich meals Spread calories evenly throughout the day Limit sodium intake Stay hydrated (ironically, more water helps flush excess sodium) Consider glucosamine, chondroitin, or fish oil supplements Maintain regular, gentle stretching or yoga Check fasting glucose weekly Incorporate low-glycemic carbs and regular exercise Keep a consistent bedtime Avoid screens 1 hour before sleep If side effects persist beyond 4–6 weeks or worsen, reconsider your dosage or discontinue under medical supervision.
02

Question drills

Open a question for its connected answer.

01What If the Trial Population Includes Subjects With a History of Benign Prostatic Hyperplasia?+

IGF-1 elevation may accelerate prostate growth in men with existing BPH. This is a known risk with all growth hormone secretagogues. Exclude subjects with symptomatic BPH (IPSS score >15) or elevated PSA (>4.0ng/mL) from enrollment, and monitor PSA at baseline, 3 months, and trial conclusion. If PSA rises by more than 1.0ng/mL during the study, discontinue MK-677 and refer for urological evaluation. The evidence linking IGF-1 to prostate cancer is contentious, but the precautionary principle applies in research settings.

SOURCE / realpeptides.co ↗
02What If a Researcher Uses MK-677 Alongside Exogenous GH in the Same Protocol?+

The combination is generally redundant and introduces unnecessary complexity. Exogenous GH suppresses natural pulsatility through negative feedback, which blunts the primary mechanism MK-677 is designed to enhance. If the goal is maximal GH elevation regardless of natural rhythm, exogenous GH alone achieves that. If the goal is to study enhanced endogenous secretion, MK-677 alone is the appropriate tool. Combining them muddies the data without clear additive benefit.

SOURCE / realpeptides.co ↗
03What If MK-677 Results Don't Match Published Trial Outcomes?+

Confirm the endpoint measurement methodology matches published protocols. Bone mineral density, for example, requires DEXA scanning at the same anatomical sites (lumbar spine L1-L4, femoral neck) using the same equipment calibration. Bioimpedance or alternative imaging modalities aren't directly comparable. Lean body mass measured via bioimpedance shows high variability depending on hydration status, time of day, and device quality. DEXA or MRI are the gold standards for replicating published findings. If methodology is sound, consider intervention duration. The BMD-52 trial's primary endpoint was 52 weeks. Meaningful bone density changes don't manifest in 12–16 week protocols, which was the typical duration in earlier studies. Investigators expecting muscle hypertrophy outcomes should note that MK-677 monotherapy produces modest lean mass increases (1–2kg over 6 months in most studies). Resistance training is required to amplify the anabolic signal, and even then, the effect size is smaller than tissue receptor occupancy data would predict. Explore combination protocols with compounds that enhance tissue-level IGF-1 receptor sensitivity if monotherapy results are suboptimal.

SOURCE / realpeptides.co ↗
04MK-677 — frequently asked questions+

MK-677 is taken by mouth as one or more capsules once daily, swallowed whole with or without food. There is no mixing, reconstitution, or injection — it is an oral small-molecule compound, not an injectable peptide. No. Because MK-677 is an oral capsule, none of the injectable-peptide supplies (bacteriostatic water, insulin syringes, alcohol swabs) apply — you simply take the capsule(s) by mouth. Each capsule is a fixed strength, so a target dose is reached by taking the matching number of capsules at that strength. The dosing table on this page lists the reference dose for each step of a documented research schedule — match your capsule strength to it rather than assuming a fixed number. Keep the capsules in their original sealed container at controlled room temperature, dry and away from heat, light and moisture, and follow the specific storage guidance supplied with your product. No refrigeration or reconstitution is required. The main practical difference is the route of administration: MK-677 is swallowed as a capsule, so there is no reconstitution, bacteriostatic water, or sterile injection technique involved. Its specific mechanism of action and the research behind it are described in the "How This Works" section on this page. No. Research-grade MK-677 is supplied strictly for laboratory and research purposes and is not an approved medicine for human use — regardless of whether an approved pharmaceutical product containing this ingredient exists. Everything here is research information, not medical advice; consult a licensed healthcare professional and the approved product labeling before any use.

SOURCE / dosagepeptide.com ↗
05What If MK-677 is Administered Alongside Other GH-Modulating Compounds?+

MK-677 for oral GH secretagogue acts through GHSR-1a receptor agonism, while compounds like CJC-1295 act as GHRH (growth hormone-releasing hormone) analogues. These pathways are complementary. GHRH stimulates the pituitary directly, while ghrelin receptor activation amplifies the GH pulse amplitude and frequency. Combining MK-677 with a GHRH analogue produces synergistic IGF-1 elevation, typically 30–50% greater than either compound alone. However, stacking with exogenous recombinant GH is counterproductive; exogenous GH suppresses endogenous secretion via negative feedback, negating the secretagogue effect entirely. If the research objective involves both exogenous and endogenous pathways, administer them in separate phases with a minimum 14-day washout between protocols.

SOURCE / realpeptides.co ↗
03

Evidence cooldown

Research context and source excerpts for a slower second read.

RESEARCH

The Evidence-Based Truth About MK-677 Research Review Findings

Here's the honest answer: MK-677 consistently delivers what it mechanistically promises. Sustained IGF-1 elevation through oral dosing without pituitary suppression. The problem is that IGF-1 elevation alone does not guarantee the outcomes researchers expect. Lean mass increases are real but modest (1–2 kg across 12 months), and they don't translate to functional strength gains in the absence of structured resistance training. The compound is not a muscle-building agent in sedentary populations. It's a GH secretagogue that requires anabolic stimulus to manifest functional benefit. The cortisol issue is more nuanced than safety analyses acknowledge. A 35% sustained increase sits in a gray zone. Not pathologic, but not physiologically inert either. Long-term studies show no overt harm, but they also weren't designed to detect subtle metabolic shifts that emerge over decades. If you're designing multi-year protocols in metabolically vulnerable populations, the cortisol effect deserves monitoring even if current evidence doesn't mandate exclusion. Appetite stimulation is the Achilles heel. It's predictable, dose-dependent, and the single biggest driver of dropout in elderly cohorts. Evening dosing mitigates but doesn't eliminate it. If your research relies on high retention rates in populations with poor baseline appetite regulation, MK-677 is the wrong tool. Consider alternatives like CJC1295 Ipamorelin combinations that bypass ghrelin pathways entirely. The compound works best in populations where appetite stimulation is neutral or beneficial, not where it's a tolerability barrier. The two-year safety data is reassuring for what it shows, but limited by what it doesn't. No cancer signal, no cardiovascular excess, no pituitary dysfunction. All true. But the cohorts studied were small (largest n=65), relatively healthy, and followed with protocols designed to detect acute adverse events rather than slow-developing metabolic consequences. MK-677 remains investigational precisely because these gaps exist. It's effective, it's mechanistically sound, and it's probably safe. But "probably" is the operative qualifier until larger, longer, and more diverse cohorts are studied. Real Peptides supports rigorous MK-677 research review efforts by providing research-grade compounds synthesized to exacting specifications. Every batch undergoes third-party purity verification to ensure your protocols aren't confounded by inactive or contaminated material. The foundation of reproducible science. The MK-677 research review literature is mature enough to guide informed protocol design but incomplete enough that novel findings remain accessible to well-designed studies. The compound's oral bioavailability and sustained activity profile make it uniquely suited to long-duration observational work that peptide-based secretagogues cannot support. If your research examines the relationship between IGF-1 modulation and aging, body composition, or metabolic health, MK-677 remains one of the most practical tools available. Provided you design around its appetite effects and monitor the cortisol variable that most published trials have dismissed too quickly.

RESEARCH

MK-677 Studied Stress Fracture — Research & Recovery

A 2019 study published in the Journal of Bone and Mineral Research found that growth hormone secretagogues elevated serum IGF-1 by 60–90% in older adults, correlating with measurable increases in bone formation markers within eight weeks. For athletes dealing with stress fractures—microcracks in bone caused by repetitive loading without adequate recovery—this IGF-1 elevation represents the physiological pathway through which MK-677 (ibutamoren) has been studied as a potential adjunct to fracture healing. The compound doesn't replace calcium, rest, or load management. It amplifies the body's existing repair cascade at the cellular level. Our team has worked with researchers studying peptide applications in musculoskeletal recovery for years. The gap between what marketing claims about MK-677 and what clinical data actually supports is wide enough to drive a truck through. 'How does MK-677 studied stress fracture recovery work at the cellular level?' MK-677 (ibutamoren) acts as a ghrelin receptor agonist, mimicking the hunger hormone ghrelin to stimulate pituitary release of growth hormone, which the liver converts to IGF-1 (insulin-like growth factor 1). IGF-1 binds to receptors on osteoblasts—bone-building cells—triggering proliferation and differentiation pathways that accelerate bone matrix deposition. In stress fracture contexts, this theoretically shortens the remodeling phase from microdamage to consolidated repair, though human fracture-specific trials remain limited compared to bone density studies. Most people assume MK-677 'heals bones faster' because it's grouped with performance enhancers. That's not mechanistically accurate. The compound doesn't directly repair microcracks—it creates a more anabolic endocrine environment where osteoblasts outpace osteoclasts (bone-resorbing cells) during the natural healing process. A 12-month trial in elderly patients showed bone mineral density increases of 1.8% at the femoral neck with 25mg daily MK-677, but none of those participants had active stress fractures—the data extrapolates healing potential from density gains, not fracture timelines. This article covers the actual studies linking MK-677 to bone remodeling, the IGF-1 mechanism behind stress fracture repair, and what research gaps remain before calling it a proven intervention.

05

Product & matchup locker

Linked catalog and comparison files.

Continue reading

Related articles

MK-677 Ibutamoren UK 2026 Research Reference

MK-677 Ibutamoren UK 2026 Research Reference Last updated: April 2026 · UK research-grade reference · For laboratory research use only — not for human consumption Table of Contents 1. Overview — why MK-677 is the refere…

Read article